ArticleAlzheimer's & dementia (New York, N. Y.)2019

A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms.

Katy Bernard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.